The incorporation of abiotic transition metal catalysis into the chemical biology space has significantly expanded the tool kit of bioorthogonal chemistries accessible for cell culture and in vivo applications. A rich variety of homogeneous and heterogeneous catalysts has shown functional compatibility with physiological conditions and biostability in complex environs, enabling their exploitation as extracellular or intracellular factories of bioactive agents. Current trends in the field are focusing on investigating new metals and sophisticated catalytic devices and toward more applied activities, such as the integration of subcellular, cell- and site-targeting capabilities or the exploration of novel biomedical applications. We present herein an overview of the latest advances in the field, highlighting the increasing role of transition metals for the controlled release of therapeutics.

Gold nanorods coated with a uniform titanium dioxide nanoshell have been prepared and used as glucose-oxidase surrogates. Remarkably, this core–shell photocatalytic nanostructure has been able to induce complete oxidation of glucose at near room temperature (32–34 °C) in a wide range of pH values with the aid of a near-infrared (NIR) irradiation source. In contrast, the uncoated gold nanorods exhibit negligible photo-oxidation response under identical experimental conditions thereby proving the photoactivity of the titania shell towards glucose oxidation. The process takes place via in situ photo-generation of singlet oxygen or hydroxyl radicals as reactive oxidative species (ROS). This underlines the role played by the core nanorods as plasmonic light harvesters in the NIR range and constitutes the first example of a NIR-activated enzyme-like catalyst.

The transformation of glucose represents a topic of great interest at different levels. In the first place, glucose is currently conceived as a green feedstock for the sustainable production of chemicals. Secondly, the depletion of glucose at the cellular level is currently envisioned as a promising strategy to treat and alter the erratic metabolism of tumoral cells. The use of natural enzymes offers multiple advantages in terms of specificity towards the glucose substrate but may lack sufficient robustness and recyclability beyond the optimal operating conditions of these natural systems. In the present work, we have evaluated the potential use of an inorganic based nanohybrid containing gold nanoparticles supported onto ordered mesoporous supports. We have performed different assays that corroborate the enzyme-mimicking response of these inorganic surrogates towards the selective conversion of glucose into gluconic acid and hydrogen peroxide. Moreover, we conclude that these enzyme-like mimicking surrogates can operate at different pH ranges and under mild reaction conditions, can be recycled multiple times and maintain excellent catalytic response in comparison with other gold-based catalysts.